Table 3.
Laboratory-based trial eligibility by race/ethnicity
| Trial | Total (N = 2185) | NHW (n = 1666) |
Black/AA (non-Hispanic) (n = 155) |
Hispanic (any) (n = 288) |
Other minority (non-Hispanic) (n = 76) |
P value |
|---|---|---|---|---|---|---|
| REMoDL-B, n (%) | .51 | |||||
| Ineligible | 194 (8.9%) | 144 (8.6%) | 16 (10.3%) | 24 (8.3%) | 10 (13.2%) | |
| Eligible | 1991 (91.1%) | 1522 (91.4%) | 139 (89.7%) | 264 (91.7%) | 66 (86.8%) | |
| ROBUST, n (%) | .20 | |||||
| Ineligible | 218 (10.0%) | 161 (9.7%) | 22 (14.2%) | 25 (8.7%) | 10 (13.2%) | |
| Eligible | 1967 (90.0%) | 1505 (90.3%) | 133 (85.8%) | 263 (91.3%) | 66 (86.8%) | |
| ECOG 1412, n (%) | .30 | |||||
| Ineligible | 237 (10.8%) | 177 (10.6%) | 23 (14.8%) | 27 (9.4%) | 10 (13.2%) | |
| Eligible | 1948 (89.2%) | 1489 (89.4%) | 132 (85.2%) | 261 (90.6%) | 66 (86.8%) | |
| PHOENIX, n (%) | .52 | |||||
| Ineligible | 261 (11.9%) | 199 (11.9%) | 17 (11.0%) | 32 (11.1%) | 13 (17.1%) | |
| Eligible | 1924 (88.1%) | 1467 (88.1%) | 138 (89.0%) | 256 (88.9%) | 63 (82.9%) | |
| CALGB 50303, n (%) | .50 | |||||
| Ineligible | 361 (16.5%) | 280 (16.8%) | 22 (14.2%) | 43 (14.9%) | 16 (21.1%) | |
| Eligible | 1824 (83.5%) | 1386 (83.2%) | 133 (85.8%) | 245 (85.1%) | 60 (78.9%) | |
| POLARIX, n (%) | .12 | |||||
| Ineligible | 362 (16.6%) | 263 (15.8%) | 34 (21.9%) | 48 (16.7%) | 17 (22.4%) | |
| Eligible | 1823 (83.4%) | 1403 (84.2%) | 121 (78.1%) | 240 (83.3%) | 59 (77.6%) | |
| GOYA, n (%) | .022 | |||||
| Ineligible | 374 (17.1%) | 270 (16.2%) | 39 (25.2%) | 48 (16.7%) | 17 (22.4%) | |
| Eligible | 1811 (82.9%) | 1396 (83.8%) | 116 (74.8%) | 240 (83.3%) | 59 (77.6%) | |
| ENGINE, n (%) | .0028 | |||||
| Ineligible | 573 (26.2%) | 409 (24.5%) | 58 (37.4%) | 83 (28.8%) | 23 (30.3%) | |
| Eligible | 1612 (73.8%) | 1257 (75.5%) | 97 (62.6%) | 205 (71.2%) | 53 (69.7%) |